Literature DB >> 16044134

Long-term renal function after hemopoietic stem cell transplantation in children.

J E Kist-van Holthe1, D Bresters, Y M Ahmed-Ousenkova, C A Goedvolk, F C H Abbink, R Wolterbeek, R G M Bredius, E K J Pauwels, A J van der Heijden.   

Abstract

Glomerular function of all long-term survivors who underwent hemopoietic stem cell transplantation (HSCT) from 1991 to 1998 (study I, n=121) was studied retrospectively. In addition, we prospectively analyzed glomerular and tubular function of all long-term surviving children who received an HSCT between 1998 and 2000 (study II, n=41). We found a lower prevalence of children with chronic renal failure (CRF) post-HSCT in our more recent cohort (study II: 10%) as compared to the older cohort (study I: 24%) 5.0 (0.7 s.d.) and 7.6 (2.4 s.d.) year's post-HSCT, respectively. Furthermore, it seems that renal function may stabilize after 1-year post-HSCT. None of the patients required dialysis or antihypertensive medication at long-term follow-up. The sole predictor of CRF in our study was high serum creatinine pre-HSCT (P=0.007), while acute renal failure within 3 months after HSCT (P=0.08) only showed a trend towards predicting CRF. We could not confirm a relation of conditioning with irradiation with CRF post-HSCT, as was shown in several other pediatric and adult studies. Proximal and distal tubular dysfunction only occurred in a minority of long-time survivors of HSCT (3-12 and 9-13%, respectively) and had no clinical consequences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044134     DOI: 10.1038/sj.bmt.1705110

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

Review 1.  Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.

Authors:  Smita Bhatia
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

2.  Glomerular and tubular function in young adults treated with stem-cell transplantation in childhood.

Authors:  Per Frisk; Johan Arvidson; Tryggve Neveus
Journal:  Pediatr Nephrol       Date:  2010-04-08       Impact factor: 3.714

Review 3.  Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies.

Authors:  Courtney D Fitzhugh; Emmanuel J Volanakis; Ombeni Idassi; Josh A Duberman; Michael R DeBaun; Debra L Friedman
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

4.  Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Paul A Hoffmeister; Sangeeta R Hingorani; Barry E Storer; K Scott Baker; Jean E Sanders
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-02       Impact factor: 5.742

Review 5.  Pediatric acute kidney injury and the subsequent risk for chronic kidney disease: is there cause for alarm?

Authors:  Vaka K Sigurjonsdottir; Swasti Chaturvedi; Cherry Mammen; Scott M Sutherland
Journal:  Pediatr Nephrol       Date:  2018-01-26       Impact factor: 3.714

Review 6.  Chronic kidney disease after hematopoietic cell transplantation: a systematic review.

Authors:  M J Ellis; C R Parikh; J K Inrig; M Kanbay; M Kambay; U D Patel
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

7.  Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.

Authors:  Michael Choi; Can-Lan Sun; Seira Kurian; Andrea Carter; Liton Francisco; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

8.  Renal tubule function in beta-thalassemia after hematopoietic stem cell transplantation.

Authors:  Achra Sumboonnanonda; Kleebsabai Sanpakit; Nuntawan Piyaphanee
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

Review 9.  Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children.

Authors:  Kiran Upadhyay; Richard N Fine
Journal:  Pediatr Nephrol       Date:  2013-08-16       Impact factor: 3.714

10.  Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.

Authors:  Daniel Wolff; Philipp Y Herzberg; Anne Herrmann; Steven Z Pavletic; Pia Heussner; Friederike Mumm; Christina Höfer; Inken Hilgendorf; Philipp G Hemmati; Ernst Holler; Hildegard Greinix; Sandra A Mitchell
Journal:  Bone Marrow Transplant       Date:  2020-07-31       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.